Literature DB >> 23793063

Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa.

Tinnakorn Chaiworapongsa1, Roberto Romero, Amy Whitten, Adi L Tarca, Gaurav Bhatti, Sorin Draghici, Piya Chaemsaithong, Jezid Miranda, Sonia S Hassan.   

Abstract

OBJECTIVE: Preeclampsia (PE) can be sub-divided into early- and late-onset phenotypes. The pathogenesis of these two phenotypes has not been elucidated. To gain insight into the mechanisms of disease, the transcriptional profiles of whole blood from women with early- and late-onset PE were examined.
METHODS: A cross-sectional study was conducted to include women with: i) early-onset PE (diagnosed prior to 34 weeks, n=25); ii) late-onset PE (after 34 weeks, n=47); and iii) uncomplicated pregnancy (n=61). Microarray analysis of mRNA expression in peripheral whole blood was undertaken using Affymetrix microarrays. Differential gene expression was evaluated using a moderated t-test (false discovery rate <0.1 and fold change >1.5), adjusting for maternal white blood cell count and gestational age. Validation by real-time qRT-PCR was performed in a larger sample size [early PE (n=31), late PE (n=72) and controls (n=99)] in all differentially expressed genes. Gene ontology analysis and pathway analysis were performed.
RESULTS: i) 43 and 28 genes were differentially expressed in early- and late-onset PE compared to the control group, respectively; ii) qRT-PCR confirmed the microarray results for early and late-onset PE in 77% (33/43) and 71% (20/28) of genes, respectively; iii) 20 genes that are involved in coagulation (SERPINI2), immune regulation (VSIG4, CD24), developmental process (H19) and inflammation (S100A10) were differentially expressed in early-onset PE alone. In contrast, only seven genes that encoded proteins involved in innate immunity (LTF, ELANE) and cell-to-cell recognition in the nervous system (CNTNAP3) were differentially expressed in late-onset PE alone. Thirteen genes that encode proteins involved in host defense (DEFA4, BPI, CTSG, LCN2), tight junctions in blood-brain barrier (EMP1) and liver regeneration (ECT2) were differentially expressed in both early- and late-onset PE.
CONCLUSION: Early- and late-onset PE are characterized by a common signature in the transcriptional profile of whole blood. A small set of genes were differentially regulated in early- and late-onset PE. Future studies of the biological function, expression timetable and protein expression of these genes may provide insight into the pathophysiology of PE.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23793063      PMCID: PMC4164302          DOI: 10.1515/jpm-2013-0082

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  203 in total

1.  Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.

Authors:  Attila Molvarec; András Szarka; Szilvia Walentin; Endre Szucs; Bálint Nagy; János Rigó
Journal:  Hypertens Res       Date:  2010-06-10       Impact factor: 3.872

2.  Metabolomics and first-trimester prediction of early-onset preeclampsia.

Authors:  Ray O Bahado-Singh; Ranjit Akolekar; Rupasri Mandal; Edison Dong; Jianguo Xia; Michael Kruger; David S Wishart; Kypros Nicolaides
Journal:  J Matern Fetal Neonatal Med       Date:  2012-04-28

3.  Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells.

Authors:  A Rajakumar; T Chu; D E Handley; K D Bunce; B Burke; C A Hubel; A Jeyabalan; D G Peters
Journal:  Placenta       Date:  2010-11-13       Impact factor: 3.481

4.  Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth.

Authors:  M Sean Esplin; Karen Merrell; Robert Goldenberg; Yinglei Lai; Jay D Iams; Brian Mercer; Catherine Y Spong; Menachem Miodovnik; Hygriv N Simhan; Peter van Dorsten; Mitchell Dombrowski
Journal:  Am J Obstet Gynecol       Date:  2010-11-11       Impact factor: 8.661

5.  Isolation of microarray-grade total RNA, microRNA, and DNA from a single PAXgene blood RNA tube.

Authors:  Mogens Kruhøffer; Lars Dyrskjøt; Thorsten Voss; Raija L P Lindberg; Ralf Wyrich; Thomas Thykjaer; Torben F Orntoft
Journal:  J Mol Diagn       Date:  2007-08-09       Impact factor: 5.568

6.  Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels.

Authors:  S Poliak; L Gollan; R Martinez; A Custer; S Einheber; J L Salzer; J S Trimmer; P Shrager; E Peles
Journal:  Neuron       Date:  1999-12       Impact factor: 17.173

7.  Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Francesca Gotsch; Jimmy Espinoza; Jyh Kae Nien; Luis Goncalves; Samuel Edwin; Yeon Mee Kim; Offer Erez; Juan Pedro Kusanovic; Beth L Pineles; Zoltan Papp; Sonia Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-01

8.  CD24: a genetic checkpoint in T cell homeostasis and autoimmune diseases.

Authors:  Yang Liu; Pan Zheng
Journal:  Trends Immunol       Date:  2007-05-24       Impact factor: 16.687

9.  Mid-gestational gene expression profile in placenta and link to pregnancy complications.

Authors:  Liis Uusküla; Jaana Männik; Kristiina Rull; Ave Minajeva; Sulev Kõks; Pille Vaas; Pille Teesalu; Jüri Reimand; Maris Laan
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

10.  Gene expression profiling of whole blood: comparison of target preparation methods for accurate and reproducible microarray analysis.

Authors:  Kristina Vartanian; Rachel Slottke; Timothy Johnstone; Amanda Casale; Stephen R Planck; Dongseok Choi; Justine R Smith; James T Rosenbaum; Christina A Harrington
Journal:  BMC Genomics       Date:  2009-01-05       Impact factor: 3.969

View more
  20 in total

1.  The profiles of soluble adhesion molecules in the "great obstetrical syndromes".

Authors:  Nikolina Docheva; Roberto Romero; Piya Chaemsaithong; Adi L Tarca; Gaurav Bhatti; Percy Pacora; Bogdan Panaitescu; Noppadol Chaiyasit; Tinnakorn Chaiworapongsa; Eli Maymon; Sonia S Hassan; Offer Erez
Journal:  J Matern Fetal Neonatal Med       Date:  2018-02-01

2.  Early pregnancy vitamin D status and risk of preeclampsia.

Authors:  Hooman Mirzakhani; Augusto A Litonjua; Thomas F McElrath; George O'Connor; Aviva Lee-Parritz; Ronald Iverson; George Macones; Robert C Strunk; Leonard B Bacharier; Robert Zeiger; Bruce W Hollis; Diane E Handy; Amitabh Sharma; Nancy Laranjo; Vincent Carey; Weilliang Qiu; Marc Santolini; Shikang Liu; Divya Chhabra; Daniel A Enquobahrie; Michelle A Williams; Joseph Loscalzo; Scott T Weiss
Journal:  J Clin Invest       Date:  2016-11-14       Impact factor: 14.808

3.  Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia - a longitudinal study.

Authors:  Roberto Romero; Piya Chaemsaithong; Adi L Tarca; Steven J Korzeniewski; Eli Maymon; Percy Pacora; Bogdan Panaitescu; Noppadol Chaiyasit; Zhong Dong; Offer Erez; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2017-03-01

4.  Early pathways, biomarkers, and four distinct molecular subclasses of preeclampsia: The intersection of clinical, pathological, and high-dimensional biology studies.

Authors:  Nándor Gábor Than; Máté Posta; Dániel Györffy; László Orosz; Gergő Orosz; Simona W Rossi; Géza Ambrus-Aikelin; András Szilágyi; Sándor Nagy; Petronella Hupuczi; Olga Török; Adi L Tarca; Offer Erez; Zoltán Papp; Roberto Romero
Journal:  Placenta       Date:  2022-03-22       Impact factor: 3.287

5.  Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study.

Authors:  Radwa Marawan AbdelHalim; Dalia Ibrahim Ramadan; Reham Zeyada; Ahmed Soliman Nasr; Iman Atef Mandour
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

Review 6.  Pre-eclampsia: pathogenesis, novel diagnostics and therapies.

Authors:  Elizabeth A Phipps; Ravi Thadhani; Thomas Benzing; S Ananth Karumanchi
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

7.  Whole blood gene expression profile associated with spontaneous preterm birth in women with threatened preterm labor.

Authors:  Yujing Jan Heng; Craig Edward Pennell; Hon Nian Chua; Jonathan Edward Perkins; Stephen James Lye
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

Review 8.  Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?

Authors:  Sinuhe Hahn; Olav Lapaire; Nandor Gabor Than
Journal:  Expert Rev Mol Diagn       Date:  2015-03-16       Impact factor: 5.225

9.  FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsia.

Authors:  Ami Ashar-Patel; Yasin Kaymaz; Augustine Rajakumar; Jeffrey A Bailey; S Ananth Karumanchi; Melissa J Moore
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

10.  Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.

Authors:  Henry Adekola; Roberto Romero; Piya Chaemsaithong; Steven J Korzeniewski; Zhong Dong; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.